Literature DB >> 12693508

5-hydroxytryptamine and atrial fibrillation: how significant is this piece in the puzzle?

Shamil Yusuf1, Naab Al-Saady, A John Camm.   

Abstract

5-Hydroxytryptamine, a recent addition to the list of hormonal triggers for atrial fibrillation (AF), may play a pivotal role in the induction of AF related not only to cardiac surgery but also to acute coronary syndromes, valvular heart disease, cardiomyopathies, alcoholism, aging, and conducting tissue disease. This review examines the supporting laboratory and clinical evidence and provides a comprehensive insight into the basic underlying mechanisms involved. It also delves into the potential benefits and limitations of 5-HT4 antagonists in the prevention and management of this arrhythmia.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12693508

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN： 1045-3873


  14 in total

Review 1.  Serotonin receptor signaling and regulation via β-arrestins.

Authors:  Laura M Bohn; Cullen L Schmid
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-10-07       Impact factor: 8.250

Review 2.  Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights.

Authors:  Jelena Kornej; Christin S Börschel; Emelia J Benjamin; Renate B Schnabel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

3.  Functional studies of the 5'-untranslated region of human 5-HT4 receptor mRNA.

Authors:  Marjorie Maillet; Monique Gastineau; Pascal Bochet; Marie-Liesse Asselin-Labat; Eric Morel; Jean-Noël Laverrière; Anne-Marie Lompré; Rodolphe Fischmeister; Frank Lezoualc'h
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

Review 4.  [New antiarrhythmic drugs for therapy of atrial fibrillation: I. Ion channel blockers].

Authors:  U Ravens; E Wettwer; U Schotten; R Wessel; D Dobrev
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2006-06

Review 5.  Atrial fibrillation in carcinoid heart disease: The role of serotonin. A review of the literature.

Authors:  C Langer; C Piper; J Vogt; J Heintze; T Butz; O Lindner; W Burchert; C Kersting; D Horstkotte
Journal:  Clin Res Cardiol       Date:  2006-11-24       Impact factor: 5.460

6.  On the presence of serotonin in mammalian cardiomyocytes.

Authors:  Klaus Pönicke; Ulrich Gergs; Igor B Buchwalow; Steffen Hauptmann; Joachim Neumann
Journal:  Mol Cell Biochem       Date:  2012-02-25       Impact factor: 3.396

7.  Association of Depression, Antidepressants With Atrial Fibrillation Risk: A Systemic Review and Meta-Analysis.

Authors:  Yonghui Fu; Shenghui Feng; Yingxiang Xu; Yuanjian Yang; Haibo Chen; Wenfeng He; Wengen Zhu; Kang Yin; Zhengbiao Xue; Bo Wei
Journal:  Front Cardiovasc Med       Date:  2022-05-11

8.  Bipolar Disorder and Schizophrenia Present Different Risks of Atrial fibrillation: A Nationwide Population-Based Analysis.

Authors:  Hung-Yu Yang; Jen-Hung Huang; Yung-Kuo Lin; Chien-Yeh Hsu; Shih-Ann Chen; Yi-Jen Chen
Journal:  Acta Cardiol Sin       Date:  2014-01       Impact factor: 2.672

Review 9.  [New developments in the antiarrhythmic therapy of atrial fibrillation].

Authors:  Ursula Ravens
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2014-02-05

10.  Phosphorylation of phospholamban and troponin I through 5-HT4 receptors in the isolated human atrium.

Authors:  Ulrich Gergs; Joachim Neumann; Andreas Simm; Rolf-Edgar Silber; Freerk Ole Remmers; Stephanie Läer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-11-11       Impact factor: 3.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.